This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Meiji Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yoshio Suzuki: Innovator in Antibody Titer-Enhancing Agents
Introduction
Yoshio Suzuki is a notable inventor based in Inzai, Japan. He has made significant contributions to the field of immunology through his innovative work on antibody titer-increasing agents. His research focuses on developing safe and effective methods to enhance vaccine efficacy.
Latest Patents
Yoshio Suzuki holds a patent for an "Antibody titer-increasing agent using lactic acid bacterium." This invention addresses the need for an adjuvant that can sustain the effects of vaccination. The agent is designed to be safe, convenient, and economical, making it accessible for individuals of all ages. The patent outlines methods for increasing antibody titers and enhancing vaccine effects using subspecies OLL1073R-1 or its culture.
Career Highlights
Throughout his career, Yoshio Suzuki has been associated with Meiji Co., Ltd., where he has contributed to various research initiatives. His work has focused on improving public health through innovative solutions in vaccine technology.
Collaborations
Yoshio has collaborated with esteemed colleagues such as Yukio Asami and Sachio Kawai. Their combined expertise has furthered the development of effective immunological agents.
Conclusion
Yoshio Suzuki's contributions to the field of immunology, particularly through his patent on antibody titer-increasing agents, highlight his commitment to enhancing vaccine efficacy. His work continues to impact public health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile